Compile Data Set for Download or QSAR
Report error Found 60 Enz. Inhib. hit(s) with all data for entry = 10989
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582048BDBM582048(US11518761, Example 107)
Affinity DataIC50: 6.16nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582049BDBM582049(US11518761, Example 135)
Affinity DataIC50: 7.05nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582050BDBM582050(US11518761, Example 121)
Affinity DataIC50: 7.41nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582051BDBM582051(US11518761, Example 42)
Affinity DataIC50: 8.37nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582044BDBM582044(US11518761, Example 6)
Affinity DataIC50: 8.70nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582052BDBM582052(US11518761, Example 124)
Affinity DataIC50: 8.87nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582053BDBM582053(US11518761, Example 109)
Affinity DataIC50: 9.79nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582054BDBM582054(US11518761, Example 111)
Affinity DataIC50: 10.2nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582076BDBM582076(US11518761, Example 157)
Affinity DataIC50: 11nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582077BDBM582077(US11518761, Example 158)
Affinity DataIC50: 11.4nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582055BDBM582055(US11518761, Example 131)
Affinity DataIC50: 11.4nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582056BDBM582056(US11518761, Example 154)
Affinity DataIC50: 11.8nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 50538668BDBM50538668(CHEMBL4634455 | US11518761, Example 159)
Affinity DataIC50: 13nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582079BDBM582079(US11518761, Example 160)
Affinity DataIC50: 13.6nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582080BDBM582080(US11518761, Example 161)
Affinity DataIC50: 14.2nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582057BDBM582057(US11518761, Example 112)
Affinity DataIC50: 14.6nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582059BDBM582059(US11518761, Example 116)
Affinity DataIC50: 15.4nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582058BDBM582058(US11518761, Example 130)
Affinity DataIC50: 15.4nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 50538668BDBM50538668(CHEMBL4634455 | US11518761, Example 159)
Affinity DataIC50: 16.5nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582038BDBM582038(US11518761, Example 23)
Affinity DataIC50: 17.2nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582081BDBM582081(US11518761, Example 175 | US11518761, Example 162)
Affinity DataIC50: 17.4nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582081BDBM582081(US11518761, Example 175 | US11518761, Example 162)
Affinity DataIC50: 17.4nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582082BDBM582082(US11518761, Example 163)
Affinity DataIC50: 18nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582061BDBM582061(US11518761, Example 127)
Affinity DataIC50: 18.4nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582062BDBM582062(US11518761, Example 54)
Affinity DataIC50: 18.9nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582063BDBM582063(US11518761, Example 83)
Affinity DataIC50: 20.6nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582064BDBM582064(US11518761, Example 78)
Affinity DataIC50: 21.7nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582043BDBM582043(US11518761, Example 5)
Affinity DataIC50: 25.3nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582046BDBM582046(US11518761, Example 17)
Affinity DataIC50: 25.4nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582065BDBM582065(US11518761, Example 88)
Affinity DataIC50: 25.4nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582039BDBM582039(US11518761, Example 9)
Affinity DataIC50: 26.3nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582066BDBM582066(US11518761, Example 113)
Affinity DataIC50: 26.5nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582067BDBM582067(US11518761, Example 152)
Affinity DataIC50: 27.3nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582083BDBM582083(US11518761, Example 164)
Affinity DataIC50: 28.3nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582068BDBM582068(US11518761, Example 128)
Affinity DataIC50: 28.3nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582069BDBM582069(US11518761, Example 132)
Affinity DataIC50: 28.4nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582085BDBM582085(US11518761, Example 166)
Affinity DataIC50: 28.9nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582084BDBM582084(US11518761, Example 165)
Affinity DataIC50: 28.9nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582070BDBM582070(US11518761, Example 86)
Affinity DataIC50: 29.6nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582071BDBM582071(US11518761, Example 151)
Affinity DataIC50: 31.3nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582072BDBM582072(US11518761, Example 153)
Affinity DataIC50: 33.8nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582073BDBM582073(US11518761, Example 125)
Affinity DataIC50: 36nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582086BDBM582086(US11518761, Example 167)
Affinity DataIC50: 36.4nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582087BDBM582087(US11518761, Example 168)
Affinity DataIC50: 37.1nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582074BDBM582074(US11518761, Example 38)
Affinity DataIC50: 37.6nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582088BDBM582088(US11518761, Example 169)
Affinity DataIC50: 37.7nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582075BDBM582075(US11518761, Example 155)
Affinity DataIC50: 38nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582089BDBM582089(US11518761, Example 170)
Affinity DataIC50: 38.6nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582090BDBM582090(US11518761, Example 171)
Affinity DataIC50: 41.1nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Vyera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 582091BDBM582091(US11518761, Example 172)
Affinity DataIC50: 45.9nMAssay Description:Certain of the compounds prepared as described above were assayed to determine their IC50 for inhibition of T. gondii CDPK1 (tgCDPK1). At least three...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/5/2023
Entry Details
US Patent

Displayed 1 to 50 (of 60 total ) | Next | Last >>
Jump to: